We're on a mission to end type 2 diabetes. Our 3-part program combines nutritional treatment with digital therapeutics, unlocking unparalleled weight loss and disease reversal.
Location: United Kingdom, England, London
Total raised: $2.35M
Founded date: 2019
Investors 3
| Date | Name | Website |
| 01.12.2020 | MMC Ventur... | mmc.vc |
| 16.12.2022 | Nesta Impa... | nestainves... |
| - | FoodLabs | foodlabs.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| - | Seed | $2.35M | - |
Mentions in press and media 8
| Date | Title | Description |
| 30.11.2022 | The UK social innovation board Nesta has secured £50 million for its latest impact investment drive | The impact VC fund arm of UK social innovation agency Nesta today announced a new £50 million funding pot to back early-stage impact startups. Founded in 2011, Nesta Impact Investments typically backs startups in the UK as well as deals acr... |
| 11.10.2021 | Atlantic Labs spins-out FoodLabs, a €100M food tech fund addressing climate and health | In the latest sign that the tech industry is pivoting toward climate and sustainability, Atlantic Food Labs — an offshoot of the Berlin fund Atlantic Labs headed by long-time tech investor Christophe F. Maire — is relaunching as FoodLabs, w... |
| 08.10.2021 | London-based startup Habitual lands $2.3M seed funding | Ian Braithwaite, cofounder and CEO and Napala Pratini, cofounder and COO, Habitual Credit: Habitual |
| 07.10.2021 | London’s healthtech Habitual specialising in diabetes reversal closes £1.7M funding to take up clinical trials | Besides COVID-19, type 2 diabetes is the most pressing healthcare problem faced by many right now. In the UK, it is estimated that one in 10 people over the age of 40 is diagnosed with type 2 diabetes. Of these, 60 percent are said to suffe... |
| 05.10.2021 | Habitual is using digital support plus food replacement to help reverse type 2 diabetes | Image Credits: Habitual London-based Habitual, a health tech startup which offers a weight loss program aimed at people with type 2 diabetes (or prediabetes) that combines “evidence-based” food replacement with digital support to help peopl... |
| 05.08.2021 | Improving the long term health of women - why we invested in Vira | I’m delighted to support the Vira team alongside Julia and Remus at LocalGlobe as they announce their £1.5 million Seed round. Menopause care had been an area of interest for me having heard experiences of women going to GPs with an array ... |
| 05.05.2021 | 8 startups reshaping the global food system | Editor’s note: This post is part of a collaboration with F&A Next, an AgFunder Network Partner. F&A Next was founded by Anterra Capital, StartLife, Rabobank, and Wageningen University & Research. F&A Next is a platform dedic... |
| - | London’s healthtech Habitual specialising in diabetes reversal closes £1.7M funding to take up clinical trials | Besides COVID-19, type 2 diabetes is the most pressing healthcare problem faced by many right now. In the UK, it is estimated that one in 10 people over the age of 40 is diagnosed with type 2 diabetes. Of these, 60 percent are said to suffe... |